前性痴呆:从遗传学到治疗方法
Francesca R Buccellato1,2, Marianna D'Anca1, Gianluca Martino Tartaglia1,2
1Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Expert opinion on investigational drugs
|April 30, 2024
概括
前性痴呆症 (FTD) 是一种神经退行性疾病,没有治愈方法. 目前的临床试验重点是基因突变,为未来的FTD疾病修饰治疗铺平了道路.
科学领域:
- 神经退行性疾病的神经退行性疾病
- 前性痴呆症 (FTD) 研究研究
背景情况:
- FTD的特点是前额叶和叶的行为变化和缩.
- 目前,FTD没有疾病修饰性治疗方法,只有症状选择.
研究的目的:
- 要总结最近批准的FTD临床试验.
- 概述FTD研究中的分子,作用机制和药理学测试.
主要方法:
- 对家族性FTD的临床试验的审查.
- 对针对特定突变或蛋白质的化合物的分析.
主要成果:
- 目前正在进行的试验正在调查基因FTD的向治疗方法.
- 研究正在探索是否针对特定的突变或共同的蛋白质沉积物.
结论:
- 临床试验正在推进FTD治疗策略.
- 未来的研究可能通过澄清治疗目标来弥合遗传和零星FTD之间的差距.
相关概念视频
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
598
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
598
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Human Genetics
564
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
564
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537


